LENZ Therapeutics, Inc. (LENZ) Stock Ticker
LENZ right now
Market factors today
Unlock the full LENZ picture
About LENZ Therapeutics, Inc.
LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for presbyopia. Corporate operations for LENZ Therapeutics are situated in Del Mar, California.
LENZ stock facts
| Ticker symbol | LENZ |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $124.2M |
| CEO | Evert Schimmelpennink |
| Employees | 152 |
| Headquarters | Solana Beach, CA, US |
| IPO date | 2021-06-25 |
| Website | www.lenz-tx.com |
What you can see for LENZ on Tickr
Live LENZ price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the LENZ report.
Rankings
FAQ
What is the ticker symbol for LENZ Therapeutics, Inc.?
The ticker symbol for LENZ Therapeutics, Inc. is LENZ, listed on the NASDAQ Global Select.
What is LENZ?
LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for…